The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

Nov. 12, 2013
Applicant:

Ait Austrian Institute of Technology Gmbh, Vienna, AT;

Inventors:

Guenter Schreier, Graz, AT;

Robert Modre-Osprian, Ligist, AT;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61J 1/03 (2006.01); A61J 3/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/021 (2006.01); A61B 5/0452 (2006.01); A61B 5/11 (2006.01); A61B 5/145 (2006.01); A61B 5/16 (2006.01); A61B 5/00 (2006.01); A61F 7/00 (2006.01); A61N 5/06 (2006.01); A61N 5/10 (2006.01); B65B 3/00 (2006.01); B65B 7/16 (2006.01); B65D 75/36 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61B 5/021 (2013.01); A61B 5/0205 (2013.01); A61B 5/0452 (2013.01); A61B 5/1118 (2013.01); A61B 5/145 (2013.01); A61B 5/165 (2013.01); A61B 5/4824 (2013.01); A61F 7/00 (2013.01); A61J 1/035 (2013.01); A61J 3/00 (2013.01); A61J 3/005 (2013.01); A61N 5/06 (2013.01); A61N 5/10 (2013.01); B65B 3/003 (2013.01); B65B 7/16 (2013.01); B65D 75/367 (2013.01); A61J 2200/30 (2013.01); A61J 2205/60 (2013.01); A61M 2230/005 (2013.01); A61M 2230/06 (2013.01); A61M 2230/30 (2013.01); A61M 2230/63 (2013.01);
Abstract

A method produces a number of medicaments with a predetermined active substance and for simultaneously making an active substance value indicating the active substance quantity contained in the medicament available. A standard value is determined for the active substance quantity of the medicaments and a maximum deviation from the standard value is predefined. An active substance value is selected within an interval cN+/−Δc or predefined and an active substance quantity is used as a reference for the preparation of the respective medicament which quantity matches the active substance value. The active substance value established is associated with the medicament and is held available together with the medicament once the medicament is prepared.


Find Patent Forward Citations

Loading…